Medical Marijuana(MJNA)
$0.00-0.00 (-50.00%)
MJNA
Medical Marijuana financials statements
$0.00
At close:-0.00 (-50.00%)
Want to see MJNA full AI Analyst Report?
Medical Marijuana (MJNA) Ratios
1,359 Followers
Medical Marijuana Ratios
MJNA's free cash flow for Q2 2026 was $594.49K. For the 2026 fiscal year, MJNA's free cash flow was increased by $4.00 and operating cash flow was $594.49K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.74 | 0.68 | 0.80 | 1.41 | 2.58 |
| Quick Ratio | 0.51 | 0.48 | 0.53 | 1.05 | 2.18 |
| Cash Ratio | 0.14 | 0.16 | 0.10 | 0.11 | 0.80 |
| Solvency Ratio | -0.05 | -0.02 | -0.25 | -1.05 | -0.37 |
| Operating Cash Flow Ratio | -0.25 | 0.15 | -0.38 | -2.21 | -0.66 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -12.50M | $ -13.75M | $ -14.28M | $ -4.89M | $ 5.90M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.04 | 0.05 | 0.11 | 0.06 |
| Debt-to-Equity Ratio | 0.05 | 0.06 | 0.07 | 0.14 | 0.07 |
| Debt-to-Capital Ratio | 0.05 | 0.05 | 0.07 | 0.12 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.05 | 0.05 | 0.07 | 0.12 | 0.06 |
| Financial Leverage Ratio | 1.33 | 1.36 | 1.39 | 1.26 | 1.17 |
| Debt Service Coverage Ratio | -3.09 | -0.25 | -40.73 | -285.04 | -15.86 |
| Interest Coverage Ratio | -3.90 | -0.00 | -38.76 | -89.69 | -6.98 |
| Debt to Market Cap | 1.04 | 1.40 | 0.24 | 0.34 | 0.07 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -2.45 | -24.51 | -0.64 | -0.46 | 0.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 72.82% | 78.22% | 66.89% | 73.54% | 78.72% |
| EBIT Margin | -7.27% | -2.33% | -29.55% | -60.95% | -13.23% |
| EBITDA Margin | -5.76% | -0.50% | -28.07% | -59.54% | -11.84% |
| Operating Profit Margin | -7.27% | -0.01% | -26.72% | -18.73% | -5.21% |
| Pretax Profit Margin | -7.51% | -4.30% | -30.24% | -61.16% | -13.98% |
| Net Profit Margin | -7.51% | -4.30% | -30.24% | -61.16% | -13.98% |
| Continuous Operations Profit Margin | -7.51% | -4.30% | -30.24% | -61.16% | -13.98% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 103.29% | 56578.04% | 113.19% | 326.43% | 268.57% |
| Return on Assets (ROA) | -1.41% | -0.95% | -7.31% | -22.27% | -5.91% |
| Return on Equity (ROE) | -1.88% | -1.29% | -10.18% | -28.11% | -6.90% |
| Return on Capital Employed (ROCE) | -1.49% | -0.00% | -7.15% | -7.55% | -2.40% |
| Return on Invested Capital (ROIC) | -1.49% | -0.00% | -7.15% | -7.55% | -2.40% |
| Return on Tangible Assets | -6.52% | -4.05% | -28.93% | -65.17% | -13.50% |
| Earnings Yield | -38.81% | -31.57% | -32.32% | -68.83% | -6.54% |
| Efficiency Ratios | |||||
| Receivables Turnover | 13.79 | 15.00 | 10.69 | 6.11 | 4.35 |
| Payables Turnover | 1.73 | 1.34 | 2.12 | 2.33 | 3.13 |
| Inventory Turnover | 2.77 | 2.55 | 3.11 | 2.71 | 2.71 |
| Fixed Asset Turnover | 5.04 | 5.08 | 4.84 | 6.27 | 44.23 |
| Asset Turnover | 0.19 | 0.22 | 0.24 | 0.36 | 0.42 |
| Working Capital Turnover Ratio | -7.14 | -8.72 | 24.30 | 3.73 | 3.28 |
| Cash Conversion Cycle | -52.30 | -104.58 | -21.00 | 38.10 | 102.08 |
| Days of Sales Outstanding | 26.48 | 24.34 | 34.14 | 59.74 | 83.91 |
| Days of Inventory Outstanding | 131.61 | 143.38 | 117.19 | 134.75 | 134.85 |
| Days of Payables Outstanding | 210.38 | 272.31 | 172.33 | 156.38 | 116.69 |
| Operating Cycle | 158.09 | 167.72 | 151.33 | 194.49 | 218.76 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -270407.00 | 0.00 | -0.58 | -5.16 | -32.87 |
| Capital Expenditure Coverage Ratio | -270407.00 | 0.00 | -0.58 | -5.16 | -186.54 |
| Operating Cash Flow Coverage Ratio | -0.54 | 0.34 | -0.69 | -1.93 | -0.93 |
| Operating Cash Flow to Sales Ratio | -0.11 | 0.07 | -0.15 | -0.59 | -0.13 |
| Free Cash Flow Yield | -56.11% | 48.09% | -43.89% | -78.98% | -6.17% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.58 | -3.00 | -3.09 | -1.45 | -15.28 |
| Price-to-Sales (P/S) Ratio | 0.19 | 0.14 | 0.94 | 0.89 | 2.14 |
| Price-to-Book (P/B) Ratio | 0.05 | 0.04 | 0.32 | 0.41 | 1.05 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.78 | 2.08 | -2.28 | -1.27 | -16.21 |
| Price-to-Operating Cash Flow Ratio | -1.78 | 2.08 | -6.19 | -1.51 | -16.29 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | 0.03 | 0.04 | -0.01 | 0.16 |
| Enterprise Value Multiple | -5.81 | -51.98 | -3.97 | -1.96 | -17.90 |
| Enterprise Value | 4.17M | 3.85M | 18.75M | 29.22M | 72.30M |
| EV to EBITDA | -5.81 | -51.98 | -3.97 | -1.96 | -17.90 |
| EV to Sales | 0.33 | 0.26 | 1.12 | 1.16 | 2.12 |
| EV to Free Cash Flow | -3.08 | 3.93 | -2.72 | -1.66 | -16.07 |
| EV to Operating Cash Flow | -3.08 | 3.93 | -7.38 | -1.98 | -16.15 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | 0.00 | 0.01 |
| Shareholders’ Equity Per Share | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.03 | 1.84 | 1.02 | 1.00 | 1.06 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.80 | 0.78 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.45 | -1.52 | 0.50 | 0.96 | 0.94 |
Currency in USD

